Emvision Medical Devices Ltd has released a press release.
Trial data confirms early ischaemia detection capabilities
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- Stage 2 Insights Confirm Diagnostic & Clinical Viability
- ASA Milestone Achieved for $0.6m Grant Payment
- Strategic A$15.28M Investment from Keysight Technologies
- EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved
- Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled
Later from EMvision Medical Devices
- Pilot Production Line Established & $1.25m Grant Received
- Stage 3 Recuitment Achieved & FDA Engagement Underway
- First Responder Device Unveiled
- Appendix 4E & Annual Report to 30 June 2024
- EMV Prepares for Trial Following Positive FDA Engagement
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices